Boehringer Ingelheim Pharma GMBH & Co.KG

Germany · Reporting entity ID 100000010823

Total reported 2019–2025

$61.1M

#146 of 2,960 reporting companies — 0.1% of all reported industry payments

$566K in general payments across 320 records, plus $60.5M in research funding across 13,991 records.

How it breaks down

General payments $565,806

Research funding $60,535,723

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.